Trial Site Detail
Drug: |
IDRX-42 |
|||
|---|---|---|---|---|
Trial: |
A First-in-human (FIH) Study of IDRX-42 in Participants With Metastatic and/or Unresectable Gastrointestinal Stromal Tumors (GIST) [Study ID: StrateGIST1] |
|||
| Conditions: | Gastrointestinal Stromal Tumor | |||
Trial Status: |
Recruiting |
|||
Hospital Vall d'Hebron119-129 |
Principal Investigator: |
Silvia Espino |
|---|---|
Contact: |
silviahurtado@vhio.net (+34) 93 274 60 00 ext 4920 |
Activation Status of this Site: |
Active |
Notes about this Site: |
|
Hospital Vall d'Hebron Website: |
http://www.vhebron.es/vhang.htm |
Navigating the Map
Use the plus (+) and minus (-) controls to zoom in/out.
Click and drag the map or use the arrows to move (pan) the map.
Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.